News Quantified

CSLLY – csl ltd sp/adr (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

LA County contractor accused of defrauding families in home remodeling projects [CBS News]

CSL (OTCMKTS:CSLLY) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.

CSL to pump $1.5bn into US plasma supply chain [Yahoo! Finance]

Karoo Health Appoints Healthtech and Physician Leader Dr. Aneesh Pakala as Chief Medical Officer [Yahoo! Finance]

Coastal Community Builders Wins Dual Gold Awards at the 2026 MUSE Creative Awards [Yahoo! Finance]

Top News Decliners

2/24 Seqirus Receives FDA Approval for FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for Adults 65 Years and Older -5.5%

4/21 CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI) -4.1%

12/9 HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -1.4%

11/15 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.2%

10/7 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%

2/17 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $124.00 price target on the stock. -0.7%

9/4 Australian shares end lower on global growth worries, but NZ rises [Reuters] -0.3%

7/1 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 -0.3%

4/9 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $110.00 price target on the stock. -0.3%

1/21 Forbes Magazine Ranks CSL Behring Among Best Employers for Diversity -0.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}